Former Pfizer Senior Corporate Counsel Joins Nutter
Nutter expands its Biotech/Pharma Intellectual Property practice with the addition of Konstantin Linnik
(Boston, MA) – The law firm of Nutter McClennen & Fish LLP announced that Konstantin Linnik, Ph.D., has joined the firm as a partner in the Intellectual Property group. He will use his extensive industry expertise to benefit biotechnology, pharmaceutical, and medical device clients and support their innovation goals. His work will focus on IP strategy; competitive analysis; patent portfolio development, licensing, enforcement and patent litigation. Before joining Nutter, Linnik was senior corporate counsel at Pfizer, the world’s largest pharmaceutical company, where he was lead patent counsel for Pfizer research units in the US, Canada, and Germany.
“Coming from an industry leader, Konstantin offers our clients the immediate experience and insights into the intellectual property issues faced by major pharmaceutical companies,” said William C. Geary III, co-managing partner of Nutter. “Adding Konstantin expands the biotech and pharma depth of our intellectual property team. This addition is part of our overall strategy to bring experienced and innovative legal counsel to pharma and biotech companies that are looking to maximize the opportunities that come with intellectual property.”
Before joining Pfizer, Linnik represented a number of biotechnology and pharmaceutical companies as external counsel. Aside from his legal training, Linnik earned a Ph.D. in cell biology from Boston University School of Medicine. Linnik is active in the Boston legal community and currently chairs the Biotechnology Committee of the Boston Patent Law Association.
About Nutter McClennen & Fish LLP
Nutter McClennen & Fish LLP represents an international roster of innovative clients involved in a range of sophisticated technologies in the medical device, biotechnology and pharmaceutical industries, as well as renowned medical institutions and research universities, emerging growth companies and angel and venture capital firms. The firm’s expertise spans IP strategy, prosecution and litigation; strategic collaborations and licensing; clinical trials and regulatory compliance; as well as M&A, capital raising and finance, government investigations and defense, and product liability. Nutter was co-founded in 1879 by Louis D. Brandeis, who later became one of the most celebrated justices of the U.S. Supreme Court in modern times.
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.